Drug Profile
Itraconazole - Sebela Pharmaceuticals
Alternative Names: Hyphanox; ONMEL; SporameltLatest Information Update: 06 Jan 2022
Price :
$50
*
At a glance
- Originator Barrier Therapeutics Inc
- Developer Sebela Pharmaceuticals
- Class Antiasthmatics; Antifungals; Antineoplastics; Azoles; Chlorobenzenes; Dioxoles; Piperazines; Small molecules; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Onychomycosis